Feature | November 14, 2013

Limited Hospital Budgets in Europe Builds Market for Refurbished Medical Imaging Equipment

November 14, 2013 — The Eurozone economic slowdown has made it difficult for hospitals, particularly in Southern Europe, to procure new imaging modalities. With streamlined budgets and escalating number of medical procedures, the need to spend less on technologies while gaining the maximum benefit from them has sustained demand for high-quality refurbished imaging equipment.
As a result, refurbished systems are now preferred across most imaging departments, including nuclear medicine, mammography and minimally invasive surgeries in private hospitals.
Frost & Sullivan's Analysis of the European Refurbished Medical Imaging Equipment Market finds the market earned revenue of $417.6 million in 2012 and estimates this to reach $582.3 million in 2019.
"Growth of the private healthcare sector has increased the uptake of high-quality imaging modalities, as private hospitals focus strongly on returns on investment," said Raghuraman Madanagopal, healthcare research analyst, Frost & Sullivan. "Refurbished medical imaging equipment provides these hospitals with an opportunity to stay ahead of competitors by conducting more advanced procedures at a lower cost."
The market, however, presents its challenges. For instance, reimbursement laws across some European regions, such as France, compel reimbursement to be halved if the equipment is older than five years. This forces some hospitals to purchase new equipment. Moreover, regulations in certain countries such as Romania and Bulgaria restrict hospitals from purchasing old equipment using state funded loans. Because almost all public hospitals are covered by the state, they opt for new systems over refurbished models.
"Government regulations that have restricted the purchase of used equipment in some regions are expected to ease following the rapid acceptance of refurbished systems globally," said Madanagopal. "With governments relaxing their regulations, the scope for these systems in the public sector will grow."
Analysis of the European Refurbished Medical Imaging Equipment Market is part of the Advanced Medical Technologies Growth Partnership Service program. Frost & Sullivan's related research services include: Western and Eastern European Image and Information Management Systems Market, Global Medical Imaging Equipment Market Outlook and U.S. and European Digital Pathology Systems Market. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.
For more information: www.frost.com

Related Content

Philips, Lumify smart-device ultrasound, S4-1 cardiac transducer, RSNA 2016
Technology | Cardiovascular Ultrasound| October 14, 2016
Philips announced at The American College of Emergency Physicians' (ACEP) annual meeting that it has received 510(k)...
Toshiba CT, picking a CT scanner, choosing a CT scanner, CT 101, what to look for in CT scanners, Aquilion ONE ViSION

The Toshiba Aquilion One Vision system is among the new generation of CT systems on the market that offers several dose lowering technologies and a hardware/software combination to enhance image quality over previous-generation scanners.

Feature | CT Angiography (CTA)| October 14, 2016 | Dave Fornell
As hospitals begin replacing their first-generation 64-slice computed tomography (CT) scanners after a decade of use,
Robert M. Califf, FDA commissioner, future of cardiovascular medicine, JACC column
News | Business| September 23, 2016
Technology advances coupled with increased use of social media and personal devices could offer new possibilities for...
GE Healthcare, Mission Health, innovation collaboration, outcomes-based agreement, imaging, business
News | Business| August 30, 2016
August 30, 2016 — Mission Health and GE Healthcare announced a novel, 10-year...
Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, most popular content, most popular stories, DAIC

The FDA clearance of the first bioresorbable stent, the Abbott Absorb, the first week of July has been the most popular story so far for all of 2016. It is the first fully dissolving stent approved for the U.S. market and many experts say this technology could be a paradigm shift in coronary and peripheral therapies in the coming years as the technology improves. 

Feature | August 05, 2016 | Dave Fornell
CT angiography, CTA, coronary CT, cardiac CT, SCCT, society of cardiovascular computed tomography, cardiac imaging
Feature | CT Angiography (CTA)| August 03, 2016 | Dave Fornell
The Society of Cardiovascular Computed Tomography (SCCT) annual meeting offers an in-depth review of all aspects of c
CT angiography, CTA, Medicare population, Harvey L. Neiman Health Policy Institute study, Neiman HPI
News | CT Angiography (CTA)| August 02, 2016
According to a new study, the last 13 years have seen substantial growth in the ordering of computed tomography...
CMS, Overall Hospital Quality Star Rating, national distribution, quailty of care
News | Business| July 26, 2016
July 25, 2016 — The Centers for Medicare and Medicaid Services (CMS) announced that it expects to launch its new Over
Siemens Healthineers, Enterprise Services, ES, U.S. launch
Technology | Cardiac Imaging| July 19, 2016
July 19, 2016 — Siemens Healthineers recently introduced an expanded Services portfolio, known as Enterprise Services
Sponsored Content | Webinar | July 19, 2016
This webinar will explain the prevalence of MRI motion artifacts, outline the related financial and time burdens asso
Overlay Init